h.mensah

TL2 · Valencia

Contributes reviews on supplier material. Based in Valencia.

Joined 2 December 2024 · last posted 4d

76 posts, newest first. Showing up to 150.

Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #94 · Practice › Dosing & titration · 24 Jul 2026 · 13 likes The arithmetic in post #93 is right; the assumption feeding it is the part to check. Concentration and dose get conflated constantly in this subcategory. Changing how…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #14 · Compounds › Tirzepatide · 22 Jul 2026 · 0 likes Answering the question post #12 raises rather than the one it answers. Two things can be true about GIP component of tirzepatide at once: the mechanism is plausible and…
Which categories are strict and which are relaxed, honestly Replied, post #23 · Start Here › Welcome · 17 Jul 2026 · 8 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Common supplements people ask about, assessed one at a time Replied, post #53 · Practice › Interactions · 16 Jul 2026 · 0 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #31 · Access › Insurance & coverage · 15 Jul 2026 · 10 likes I have three months of notes on Prior authorisation and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #81 · Analytics › Home & field testing · 13 Jul 2026 · 2 likes Post #79 describes the usual case. This is about the unusual one. Consumer-accessible tests came up in a thread eighteen months ago and was answered well. I cannot find…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #16 · Practice › Interactions · 11 Jul 2026 · 19 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Blinding yourself: practical methods and their limits — the long version Replied, post #9 · Research Methods › N-of-1 designs · 10 Jul 2026 · 0 likes Blinding yourself is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #37 · Evidence › Journal club · 8 Jul 2026 · 30 likes Coming back to post #35, because the follow-up matters more than the original answer. Sessions on negative or null results are consistently the most instructive and the…
Tracking a shortage from primary sources rather than rumour Replied, post #83 · Access › Shortages · 3 Jul 2026 · 20 likes Saving this. It is the version I will quote when the question comes round again.
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #14 · Analytics › Mass spectrometry · 29 Jun 2026 · 0 likes Picking up post #11: that is the part I would want checked first. Resolution and mass accuracy are different specifications. An instrument can resolve two species and…
Insurance and replacement policies, compared Replied, post #50 · Sourcing › Logistics · 29 Jun 2026 · 14 likes Insurance and replacement policies looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #114 · Practice › Storage & stability · 9 Jun 2026 · 7 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #2 · Evidence › Journal club · 25 May 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. On balance I…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #27 · Practice › Storage & stability · 14 May 2026 · 8 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Follow-up: Sleep quality changes during weight loss Replied, post #12 · Wellbeing › Sleep · 28 Apr 2026 · 10 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here. That is where I would start, not where…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #119 · Practice › Reconstitution · 25 Apr 2026 · 2 likes This is the first time the answer has come with its own limits attached. Appreciated.
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #49 · Practice › Administration · 24 Apr 2026 · 18 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
How to ask about something you suspect is a bad idea Replied, post #79 · Start Here › How to Ask · 21 Apr 2026 · 20 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Follow-up: State-level differences that actually matter Replied, post #84 · Regional › North America · 8 Apr 2026 · 0 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction. This is where my knowledge…
Choosing which test to pay for, given a fixed budget Replied, post #47 · Sourcing › Independent verification · 31 Mar 2026 · 27 likes Sensible. I would want the same detail before I acted on it either.
A site rotation scheme that is easy enough to actually follow Replied, post #25 · Practice › Administration · 22 Mar 2026 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
Grapefruit: why this class is not the class that cares Replied, post #44 · Practice › Interactions · 15 Mar 2026 · 23 likes Post #43 is right about the mechanism and I think understates the practical bit. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #119 · Practice › Interactions · 25 Feb 2026 · 13 likes The arithmetic in post #116 is right; the assumption feeding it is the part to check. The documentation on Warfarin and altered intake is better than this thread and I…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #93 · Access › Pricing · 18 Feb 2026 · 8 likes Larger orders shift risk as well as price, because more of your material then comes from one lot. It cost nothing to check and would have cost something not to.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #53 · Outcomes › Progress reports · 14 Feb 2026 · 0 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. That has been true for the cases I have…
MHRA statements, read directly Replied, post #87 · Regional › UK & Ireland · 12 Feb 2026 · 2 likes I read post #83 twice before replying, because I had assumed the opposite. Importing for personal use: importing a prescription-only medicine without a prescription is…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #84 · Wellbeing › Mental health · 30 Jan 2026 · 0 likes One more thing on Anxiety that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #65 · Clinical › Special populations · 1 Jan 2026 · 4 likes Post #63 and I disagree about the size of the effect, not about the direction. I changed my mind about older adults after someone here asked me for the source and I…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #77 · Practice › Interactions · 27 Dec 2025 · 1 like Before the thread moves on from Warfarin and altered intake — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #15 · Access › International · 17 Dec 2025 · 9 likes I read post #13 twice before replying, because I had assumed the opposite. I have three months of notes on Language barriers in accessing and the honest summary is that…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #44 · Compounds › Semaglutide · 13 Dec 2025 · 6 likes Adding the measurement that post #41 says would settle it. Adding the boring version of semaglutide solutions, because the interesting version keeps getting posted and…
Tracking a preprint to publication: a worked example Replied, post #49 · Evidence › Preprints · 4 Dec 2025 · 0 likes I would put moderate confidence on the mainstream reading of tracking a preprint and no more. That is not scepticism for its own sake; it is where the sourcing actually…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #28 · Data & Tools › Calculators · 4 Dec 2025 · 8 likes Genuine question rather than a rhetorical one: has anyone here actually observed Feature request, as opposed to read about it? The thread is long and I cannot tell.
Reused chromatograms across lots: how to spot it — what changed since Replied, post #3 · Analytics › COA interpretation · 28 Nov 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Amylin receptor signalling and satiety Replied, post #27 · Pharmacology › Receptor biology · 3 Nov 2025 · 4 likes Worth separating two things that post #25 runs together. GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce weight…
Can a home kit substitute for a laboratory report? A careful no Replied, post #41 · Analytics › Home & field testing · 29 Oct 2025 · 0 likes Building on post #38 rather than restating it. The honest cost comparison is a home kit against a single independent submission. For most people the second answers the…
Publishing an inconvenient result: a case study — the long version Replied, post #7 · Sourcing › Independent verification · 11 Oct 2025 · 23 likes I would rather this thread reach "we do not know" about Publishing an inconvenient result than reach a confident answer that nobody can support when asked.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #141 · Data & Tools › Calculators · 6 Oct 2025 · 20 likes Adding a data point of agreement rather than a data point.
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #39 · Pharmacology › Receptor biology · 13 Sep 2025 · 29 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #102 · Access › Insurance & coverage · 1 Sep 2025 · 4 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #12 · Sourcing › Regulatory · 24 Aug 2025 · 10 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. That is all the detail I have. Someone…
Asking about a compound your prescriber has not heard of Replied, post #113 · Clinical › Prescriber conversations · 2 Aug 2025 · 10 likes Post #110 describes the usual case. This is about the unusual one. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
Research-use-only labelling: what it means and what it does not Replied, post #10 · Sourcing › Regulatory · 9 Jul 2025 · 9 likes Adding the boring version of research-use-only labelling, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Coming back to: What published stability data actually covers, and what it does not Replied, post #81 · Practice › Storage & stability · 7 Jul 2025 · 9 likes This settles it for me, at least until somebody posts a reason it should not.
Repeatability versus intermediate precision Replied, post #119 · Analytics › Method validation · 2 Jul 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
What I would record differently if I started again — the long version Replied, post #2 · Outcomes › Progress reports · 12 Jun 2025 · 9 likes The opening post answers the question as asked. The question underneath it is different. The best progress reports here read as records rather than as arguments, and…
[2026 update] An appeal that failed, and what I would do differently Replied, post #71 · Access › Insurance & coverage · 11 Jun 2025 · 0 likes I read the earlier replies on appeal twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #50 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #26 · Evidence › Journal club · 4 Jun 2025 · 0 likes Post #23 answers the question as asked. The question underneath it is different. Counterpoint on CagriSema phase 2 combination paper, offered without confidence: the…
Half-life, steady state, and accumulation worked through Replied, post #48 · Pharmacology › Pharmacokinetics · 31 May 2025 · 5 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. Albumin binding: semaglutide binds albumin through a fatty side chain, which…
Pregnancy as an absolute contraindication Replied, post #95 · Safety › Contraindications · 20 May 2025 · 21 likes This follows post #92 rather than contradicting it. Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #52 · Sourcing › Independent verification · 5 May 2025 · 0 likes I think the Janoshik question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Follow-up: Documentation that appears only after payment Replied, post #21 · Sourcing › Red flags · 25 Apr 2025 · 13 likes Adding a small correction to the Documentation summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #97 · Evidence › Journal club · 21 Apr 2025 · 4 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
Units, standards, and other things that quietly hold the world together Replied, post #17 · Lounge › Off topic · 11 Apr 2025 · 0 likes Second-hand on units, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #3 · Analytics › Method validation · 9 Apr 2025 · 23 likes Coming back to the opening post, because the follow-up matters more than the original answer. The limit of quantitation determines what the impurity table can honestly…
Follow-up: What other technical communities get right that we do not Replied, post #61 · Lounge › Off topic · 7 Apr 2025 · 7 likes Not a technical point, just an observation: the register here holds because people correct themselves in public and nobody scores points off it. That is rarer than the…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #45 · Practice › Reconstitution · 6 Apr 2025 · 31 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
Charge states for a 4 kDa peptide, worked through Replied, post #129 · Analytics › Mass spectrometry · 17 Mar 2025 · 5 likes On post #125 — agreed on the reasoning, with one qualification. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #102 · Access › International · 16 Mar 2025 · 5 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #37 · Compounds › Semaglutide · 12 Mar 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Validating a method you did not develop — does this still hold? Replied, post #41 · Analytics › Method validation · 24 Feb 2025 · 0 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
SNAC and the mechanism of oral peptide absorption Replied, post #12 · Compounds › Oral incretins · 23 Feb 2025 · 30 likes Bookmarking this. I will come back when I have something worth adding.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #24 · Practice › Reconstitution · 1 Feb 2025 · 28 likes Coming back to post #22, because the follow-up matters more than the original answer. Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #6 · Practice › Dosing & titration · 28 Jan 2025 · 3 likes On Escalating every six weeks instead the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #94 · Compounds › Tirzepatide · 17 Dec 2024 · 5 likes No notes. Posting so the count is not one.
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #2 · Compounds › Semaglutide · 17 Dec 2024 · 20 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 9 Dec 2024 · 1 like Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
EMA product information as a primary source — does this still hold? Replied, post #14 · Regional › European Union · 14 Nov 2024 · 22 likes That reframing is the whole thing. The facts I already had.
When a red flag was a misunderstanding, and the retraction Replied, post #38 · Sourcing › Red flags · 21 Oct 2024 · 17 likes My position on red flag is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #5 · Compounds › Secretagogues & GH axis · 21 Sep 2024 · 24 likes The opening post put the caveat in the right place and I want to underline it. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
Blind submission and why it changes minds Replied, post #62 · Sourcing › Independent verification · 15 Sep 2024 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. It is worth stating the boring…
Circumference measurements as a poor man's composition estimate Replied, post #40 · Outcomes › Body composition · 4 Aug 2024 · 0 likes Post #39 is the version of this I will quote in future. One addition. The most useful protocol is the one you will actually repeat identically. An imperfect measurement…
Guidelines revision: what changed and why Replied, post #85 · Meta › Announcements · 27 Jul 2024 · 0 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists. If the premise is…
Cold packs, phase-change material, and what survives ten days Replied, post #103 · Sourcing › Logistics · 14 Jul 2024 · 3 likes That matches what I have seen, for whatever a single anecdote is worth.